English
简体中文
Total: £ 56.28
Published Date: 2025-09-15 | Pages: 95 | Tables: 109 | Pharma & Healthcare
The global market for Liraglutide was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
North American market for Liraglutide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Liraglutide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Liraglutide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Liraglutide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liraglutide by region & country, by Type, and by Application.
The Liraglutide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liraglutide.
Market Segmentation
By Company
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Segment by Type
Pills
Liquid
Segment by Application
Hospital
Drug Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Liraglutide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Liraglutide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Liraglutide Product Introduction
1.2 Global Liraglutide Market Size Forecast
1.2.1 Global Liraglutide Sales Value (2020-2031)
1.2.2 Global Liraglutide Sales Volume (2020-2031)
1.2.3 Global Liraglutide Sales Price (2020-2031)
1.3 Liraglutide Market Trends & Drivers
1.3.1 Liraglutide Industry Trends
1.3.2 Liraglutide Market Drivers & Opportunity
1.3.3 Liraglutide Market Challenges
1.3.4 Liraglutide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liraglutide Players Revenue Ranking (2024)
2.2 Global Liraglutide Revenue by Company (2020-2025)
2.3 Global Liraglutide Players Sales Volume Ranking (2024)
2.4 Global Liraglutide Sales Volume by Company Players (2020-2025)
2.5 Global Liraglutide Average Price by Company (2020-2025)
2.6 Key Manufacturers Liraglutide Manufacturing Base and Headquarters
2.7 Key Manufacturers Liraglutide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Liraglutide
2.9 Liraglutide Market Competitive Analysis
2.9.1 Liraglutide Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Liraglutide Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pills
3.1.2 Liquid
3.2 Global Liraglutide Sales Value by Type
3.2.1 Global Liraglutide Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Liraglutide Sales Value, by Type (2020-2031)
3.2.3 Global Liraglutide Sales Value, by Type (%) (2020-2031)
3.3 Global Liraglutide Sales Volume by Type
3.3.1 Global Liraglutide Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Liraglutide Sales Volume, by Type (2020-2031)
3.3.3 Global Liraglutide Sales Volume, by Type (%) (2020-2031)
3.4 Global Liraglutide Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Liraglutide Sales Value by Application
4.2.1 Global Liraglutide Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Liraglutide Sales Value, by Application (2020-2031)
4.2.3 Global Liraglutide Sales Value, by Application (%) (2020-2031)
4.3 Global Liraglutide Sales Volume by Application
4.3.1 Global Liraglutide Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Liraglutide Sales Volume, by Application (2020-2031)
4.3.3 Global Liraglutide Sales Volume, by Application (%) (2020-2031)
4.4 Global Liraglutide Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Liraglutide Sales Value by Region
5.1.1 Global Liraglutide Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Liraglutide Sales Value by Region (2020-2025)
5.1.3 Global Liraglutide Sales Value by Region (2026-2031)
5.1.4 Global Liraglutide Sales Value by Region (%), (2020-2031)
5.2 Global Liraglutide Sales Volume by Region
5.2.1 Global Liraglutide Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Liraglutide Sales Volume by Region (2020-2025)
5.2.3 Global Liraglutide Sales Volume by Region (2026-2031)
5.2.4 Global Liraglutide Sales Volume by Region (%), (2020-2031)
5.3 Global Liraglutide Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Liraglutide Sales Value, 2020-2031
5.4.2 North America Liraglutide Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Liraglutide Sales Value, 2020-2031
5.5.2 Europe Liraglutide Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Liraglutide Sales Value, 2020-2031
5.6.2 Asia Pacific Liraglutide Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Liraglutide Sales Value, 2020-2031
5.7.2 South America Liraglutide Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Liraglutide Sales Value, 2020-2031
5.8.2 Middle East & Africa Liraglutide Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liraglutide Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Liraglutide Sales Value
6.2.1 Key Countries/Regions Liraglutide Sales Value, 2020-2031
6.2.2 Key Countries/Regions Liraglutide Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Liraglutide Sales Value, 2020-2031
6.3.2 United States Liraglutide Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Liraglutide Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Liraglutide Sales Value, 2020-2031
6.4.2 Europe Liraglutide Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Liraglutide Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Liraglutide Sales Value, 2020-2031
6.5.2 China Liraglutide Sales Value by Type (%), 2024 VS 2031
6.5.3 China Liraglutide Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Liraglutide Sales Value, 2020-2031
6.6.2 Japan Liraglutide Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Liraglutide Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Liraglutide Sales Value, 2020-2031
6.7.2 South Korea Liraglutide Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Liraglutide Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Liraglutide Sales Value, 2020-2031
6.8.2 Southeast Asia Liraglutide Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Liraglutide Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Liraglutide Sales Value, 2020-2031
6.9.2 India Liraglutide Sales Value by Type (%), 2024 VS 2031
6.9.3 India Liraglutide Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 HEC Pharm
7.1.1 HEC Pharm Company Information
7.1.2 HEC Pharm Introduction and Business Overview
7.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 HEC Pharm Liraglutide Product Offerings
7.1.5 HEC Pharm Recent Development
7.2 Bachem
7.2.1 Bachem Company Information
7.2.2 Bachem Introduction and Business Overview
7.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Bachem Liraglutide Product Offerings
7.2.5 Bachem Recent Development
7.3 Bharat Pharmaceuticals
7.3.1 Bharat Pharmaceuticals Company Information
7.3.2 Bharat Pharmaceuticals Introduction and Business Overview
7.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bharat Pharmaceuticals Liraglutide Product Offerings
7.3.5 Bharat Pharmaceuticals Recent Development
7.4 Kingpep Biotechnology
7.4.1 Kingpep Biotechnology Company Information
7.4.2 Kingpep Biotechnology Introduction and Business Overview
7.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Kingpep Biotechnology Liraglutide Product Offerings
7.4.5 Kingpep Biotechnology Recent Development
7.5 Shenzhen JYMed Technology
7.5.1 Shenzhen JYMed Technology Company Information
7.5.2 Shenzhen JYMed Technology Introduction and Business Overview
7.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Shenzhen JYMed Technology Liraglutide Product Offerings
7.5.5 Shenzhen JYMed Technology Recent Development
7.6 Wuxi Asiapeptide
7.6.1 Wuxi Asiapeptide Company Information
7.6.2 Wuxi Asiapeptide Introduction and Business Overview
7.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Wuxi Asiapeptide Liraglutide Product Offerings
7.6.5 Wuxi Asiapeptide Recent Development
7.7 AmbioPharm
7.7.1 AmbioPharm Company Information
7.7.2 AmbioPharm Introduction and Business Overview
7.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 AmbioPharm Liraglutide Product Offerings
7.7.5 AmbioPharm Recent Development
8 Industry Chain Analysis
8.1 Liraglutide Industrial Chain
8.2 Liraglutide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Liraglutide Sales Model
8.5.2 Sales Channel
8.5.3 Liraglutide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Liraglutide Market Trends
Table 2. Liraglutide Market Drivers & Opportunity
Table 3. Liraglutide Market Challenges
Table 4. Liraglutide Market Restraints
Table 5. Global Liraglutide Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Liraglutide Revenue Market Share by Company (2020-2025)
Table 7. Global Liraglutide Sales Volume by Company (2020-2025) & (K MT)
Table 8. Global Liraglutide Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Liraglutide Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Liraglutide Manufacturing Base and Headquarters
Table 11. Key Manufacturers Liraglutide Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Liraglutide
Table 13. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Liraglutide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Liraglutide Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Liraglutide Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Liraglutide Sales Market Share in Value by Type (2020-2025)
Table 20. Global Liraglutide Sales Market Share in Value by Type (2026-2031)
Table 21. Global Liraglutide Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
Table 22. Global Liraglutide Sales Volume by Type (2020-2025) & (K MT)
Table 23. Global Liraglutide Sales Volume by Type (2026-2031) & (K MT)
Table 24. Global Liraglutide Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Liraglutide Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Liraglutide Price by Type (2020-2025) & (USD/MT)
Table 27. Global Liraglutide Price by Type (2026-2031) & (USD/MT)
Table 28. Global Liraglutide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Liraglutide Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Liraglutide Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Liraglutide Sales Market Share in Value by Application (2020-2025)
Table 32. Global Liraglutide Sales Market Share in Value by Application (2026-2031)
Table 33. Global Liraglutide Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
Table 34. Global Liraglutide Sales Volume by Application (2020-2025) & (K MT)
Table 35. Global Liraglutide Sales Volume by Application (2026-2031) & (K MT)
Table 36. Global Liraglutide Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Liraglutide Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Liraglutide Price by Application (2020-2025) & (USD/MT)
Table 39. Global Liraglutide Price by Application (2026-2031) & (USD/MT)
Table 40. Global Liraglutide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Liraglutide Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Liraglutide Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Liraglutide Sales Value by Region (2020-2025) & (%)
Table 44. Global Liraglutide Sales Value by Region (2026-2031) & (%)
Table 45. Global Liraglutide Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
Table 46. Global Liraglutide Sales Volume by Region (2020-2025) & (K MT)
Table 47. Global Liraglutide Sales Volume by Region (2026-2031) & (K MT)
Table 48. Global Liraglutide Sales Volume by Region (2020-2025) & (%)
Table 49. Global Liraglutide Sales Volume by Region (2026-2031) & (%)
Table 50. Global Liraglutide Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Liraglutide Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Liraglutide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Liraglutide Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Liraglutide Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Liraglutide Sales Volume, (2020-2025) & (K MT)
Table 56. Key Countries/Regions Liraglutide Sales Volume, (2026-2031) & (K MT)
Table 57. HEC Pharm Company Information
Table 58. HEC Pharm Introduction and Business Overview
Table 59. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. HEC Pharm Liraglutide Product Offerings
Table 61. HEC Pharm Recent Development
Table 62. Bachem Company Information
Table 63. Bachem Introduction and Business Overview
Table 64. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Bachem Liraglutide Product Offerings
Table 66. Bachem Recent Development
Table 67. Bharat Pharmaceuticals Company Information
Table 68. Bharat Pharmaceuticals Introduction and Business Overview
Table 69. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Bharat Pharmaceuticals Liraglutide Product Offerings
Table 71. Bharat Pharmaceuticals Recent Development
Table 72. Kingpep Biotechnology Company Information
Table 73. Kingpep Biotechnology Introduction and Business Overview
Table 74. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Kingpep Biotechnology Liraglutide Product Offerings
Table 76. Kingpep Biotechnology Recent Development
Table 77. Shenzhen JYMed Technology Company Information
Table 78. Shenzhen JYMed Technology Introduction and Business Overview
Table 79. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Shenzhen JYMed Technology Liraglutide Product Offerings
Table 81. Shenzhen JYMed Technology Recent Development
Table 82. Wuxi Asiapeptide Company Information
Table 83. Wuxi Asiapeptide Introduction and Business Overview
Table 84. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Wuxi Asiapeptide Liraglutide Product Offerings
Table 86. Wuxi Asiapeptide Recent Development
Table 87. AmbioPharm Company Information
Table 88. AmbioPharm Introduction and Business Overview
Table 89. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. AmbioPharm Liraglutide Product Offerings
Table 91. AmbioPharm Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Liraglutide Downstream Customers
Table 95. Liraglutide Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Liraglutide Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Liraglutide Sales Volume (2020-2031) & (K MT)
Figure 5. Global Liraglutide Sales Price (2020-2031) & (USD/MT)
Figure 6. Liraglutide Report Years Considered
Figure 7. Global Liraglutide Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Liraglutide Players Sales Volume Ranking (2024) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Liraglutide Revenue in 2024
Figure 10. Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Pills Picture
Figure 12. Liquid Picture
Figure 13. Global Liraglutide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Liraglutide Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Liraglutide Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
Figure 16. Global Liraglutide Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Liraglutide Price by Type (2020-2031) & (USD/MT)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Drug Store
Figure 20. Global Liraglutide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Liraglutide Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Liraglutide Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
Figure 23. Global Liraglutide Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Liraglutide Price by Application (2020-2031) & (USD/MT)
Figure 25. North America Liraglutide Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Liraglutide Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Liraglutide Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Liraglutide Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Liraglutide Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Liraglutide Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Liraglutide Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Liraglutide Sales Volume (%), (2020-2031)
Figure 37. United States Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 43. China Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 45. China Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 55. India Liraglutide Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Liraglutide Sales Value by Type (%), 2024 VS 2031
Figure 57. India Liraglutide Sales Value by Application (%), 2024 VS 2031
Figure 58. Liraglutide Industrial Chain
Figure 59. Liraglutide Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
